Clinical trial
Phase II, Multicenter, Open-label, Prospective, Non-randomized Study to Evaluate the Safety and Efficacy of ARI0002h, a CAR-T Cell Against BCMA, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia
NCT06830733 is registered in ClinicalTrials.gov with Fundacion Clinic per a la Recerca Biomédica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II, Multicenter, Open-label, Prospective, Non-randomized Study to Evaluate the Safety and Efficacy of ARI0002h, a CAR-T Cell Against BCMA, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia
- Lead sponsor
- Fundacion Clinic per a la Recerca Biomédica
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- April 30, 2025
- Completion date
- December 31, 2027
- Enrollment
- 25 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.